[EN] NEW BICYCLIC ANGIOTENSIN II AGONISTS<br/>[FR] NOUVEAUX AGONISTES BICYCLIQUES D'ANGIOTENSINE II
申请人:VICORE PHARMA AB
公开号:WO2004046128A1
公开(公告)日:2004-06-03
There is provided compounds of formula (I), wherein R1a, R1b, n, Y1, Y2, Y3, Y4, Z1, Z2, R2 and R3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.